David Regnery plans sale of 5,588 common shares

A holder has filed a notice of proposed sale under Rule 144 to sell 5,588 shares of common stock through UBS Financial Services, Inc. on or about February 10, 2026 on the NYSE, with an aggregate market value of $2,573,609.28.

Rhea-AI Filing Summary

A holder has filed a notice of proposed sale under Rule 144 to sell 5,588 shares of common stock through UBS Financial Services, Inc. on or about February 10, 2026 on the NYSE, with an aggregate market value of $2,573,609.28. The filing notes that 221,331,905 shares of common stock are outstanding. The seller previously sold 987 common shares on February 6, 2026 for gross proceeds of $445,213.30, and the shares to be sold were acquired via RSU grants on February 6 and 7, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for TT disclose about upcoming share sales?

The Form 144 discloses a proposed sale of 5,588 common shares. These shares, valued at $2,573,609.28 in total, are planned to be sold on or about February 10, 2026 on the NYSE through UBS Financial Services, Inc. under Rule 144.

How many TT shares is the insider planning to sell and what is their value?

The filing reports a planned sale of 5,588 common shares. The aggregate market value of these shares is listed as $2,573,609.28. This transaction is intended to be executed on the NYSE through UBS Financial Services, Inc. around February 10, 2026.

What prior TT share sales are reported in this Form 144 notice?

The notice reports a prior sale of 987 common shares. That transaction occurred on February 6, 2026 and generated gross proceeds of $445,213.30. This historical sale is disclosed as part of the three-month lookback required in the Rule 144 information table.

How were the TT shares in the planned Form 144 sale acquired?

The shares were acquired through RSU grants from the issuer. The table shows 2,460 common shares acquired on February 6, 2026 and 3,128 common shares acquired on February 7, 2026, both identified as RSU-related acquisitions from the issuer.

What does the Form 144 say about TT shares outstanding?

The filing lists 221,331,905 common shares outstanding. This figure provides context for the planned sale of 5,588 shares under Rule 144, indicating the overall size of the issuer’s equity base relative to the proposed transaction.

Which broker and exchange are involved in the TT Form 144 share sale?

The planned sale will be executed through UBS Financial Services, Inc. The broker’s address is given as 11 Madison Ave, 4th Floor, New York, NY 10010, and the shares are intended to be sold on the NYSE according to the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001715932
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Trane Technologies plc
SEC File Number	001-34400
Address of Issuer	170/175 LAKEVIEW DRIVE AIRSIDE BUSINESS PARK, SWORDS, CO. DUBLIN IRELAND 00000
Phone	732-652-7000
Name of Person for Whose Account the Securities are To Be Sold	Regnery David S
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc 11 Madison Ave 4th Floor New York NY 10010	5588	2573609.28	221331905	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/06/2026	RSU	Issuer			2460	02/06/2026	NA
Common	02/07/2026	RSU	Issuer			3128	02/07/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Regnery 170/175 LAKEVIEW DRIVE AIRSIDE BUSINESS PARK, SWORDS, CO. DUBLIN L2 00000	Common	02/06/2026	987	445213.30

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/02/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for David Regnery
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)